CHOLESTYRAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Cholestyramine patents expire, and what generic alternatives are available?
Cholestyramine is a drug marketed by Ajanta Pharma Ltd, Alkem Labs Ltd, Ani Pharms, Endo Operations, Epic Pharma Llc, Ivax Sub Teva Pharms, Tagi, Teva, Upsher Smith Labs, Zydus Pharms, and Teva Pharms. and is included in seventeen NDAs.
The generic ingredient in CHOLESTYRAMINE is cholestyramine. There are eight drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cholestyramine
A generic version of CHOLESTYRAMINE was approved as cholestyramine by EPIC PHARMA LLC on August 15th, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CHOLESTYRAMINE?
- What are the global sales for CHOLESTYRAMINE?
- What is Average Wholesale Price for CHOLESTYRAMINE?
Summary for CHOLESTYRAMINE
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 17 |
| Finished Product Suppliers / Packagers: | 12 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 39 |
| Drug Prices: | Drug price information for CHOLESTYRAMINE |
| DailyMed Link: | CHOLESTYRAMINE at DailyMed |
Recent Clinical Trials for CHOLESTYRAMINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Centre Hospitalier Universitaire de Nice | N/A |
| Eli Lilly and Company | Phase 1 |
| Loxo Oncology, Inc. | Phase 1 |
Pharmacology for CHOLESTYRAMINE
| Drug Class | Bile Acid Sequestrant |
| Mechanism of Action | Bile-acid Binding Activity |
US Patents and Regulatory Information for CHOLESTYRAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Pharms | CHOLESTYRAMINE LIGHT | cholestyramine | POWDER;ORAL | 202902-001 | Apr 25, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva | CHOLESTYRAMINE LIGHT | cholestyramine | POWDER;ORAL | 074348-001 | May 28, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva | CHOLESTYRAMINE LIGHT | cholestyramine | POWDER;ORAL | 074348-002 | May 28, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
